Review Article
Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
Table 2
Studies evaluating the effect of anthocyanins on hepatic lipid metabolism and hepatocellular lipotoxicity in vitro.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMPK: adenosine monophosphate protein kinase; Srebp1c: sterol regulated element binding protein 1c; ACC: acetyl-coenzyme A carboxylase; p: phospho; glycerol 3 phophate acyl transferase; PKC: protein kinase C; OMM: outer mitochondrial membrane; SOD: superoxide dismutase; MAPK: mitogen associated protein kinase; Nrf2: nuclear factor erythroid 2-related factor 2; PPAR: peroxisomes proliferator activated receptor ; ROS: reactive oxygen species; GSH: reduced glutathione; PKA: protein kinase A; CREB: cAMP-response element binding protein; CPT-1: carnitine-palmytoil-transferase-1; ACN: anthocyanins; OA: oleic acid; tBH: tert-butyl hydroperoxide; MTT: 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; LDH: lactate dehydrogenase; TBARS: thiobarbituric acid reacting substances. |